Wednesday, July 18, 2018

Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications.


from Reuters: Health News https://ift.tt/2L36EpB

Related Posts:

  • LATEST HEALTH NEWSMany of the largest U.S. pharmacies and drug distributors do not have Teva Pharmaceutical Industries Ltd's generic version of the life-saving EpiPen allergy treatment five months after it was approved for sale in the United S… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Although extremely preterm birth is no longer the death sentence it once was, the tiniest preemies still have low survival odds and are likely to have severe impairments if they live, a research review sugg… Read More
  • LATEST HEALTH NEWSPolish authorities will install cameras in slaughterhouses and employ more health inspectors to prevent exports of contaminated beef to other EU countries, chief veterinarian Pawel Niemczuk said on Thursday, after a TV report… Read More
  • LATEST HEALTH NEWSCancer patients in developing nations are being denied basic pain relief, often because of excessive fears about opioid abuse, the World Health Organisation (WHO) said on Thursday. from Reuters: Health News https://reut.… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Teens and young men in correctional facilities are at increased risk of dying by suicide, but they are otherwise fairly similar to unincarcerated youth who take their own lives, a U.S. study suggests. … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner